Financials

News Discussions Technicals Seasonals

TCF fundamentals

Overview Statements Statistics Dividends Earnings Revenue

Key facts

—

—

—

—

—

—

—

—

About

TheraCryf Plc is a clinical stage drug development company, which engages in the development of focussing on oncology and neuropsychiatry. Its pipeline includes SFX-01: Breast cancer, SFX-01:neurodevelopmental disorders, and Other Programmes. The company was founded by Stephen Franklin in 2007 and is headquartered in Nether Alderley, CH.

Valuation

Fundamental metrics to determine fair value of the stock

Summary

No data available

There's currently no market capitalization, revenue or net income data to show.

Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

TCF does not pay dividends

The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company